Leeward Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-852
Closed -$222K 87
2024
Q4
$222K Buy
+852
New +$253K 0.08% 84
2023
Q3
Sell
-1,310
Closed -$291K 78
2023
Q2
$291K Sell
1,310
-8,691
-87% -$2.02M 0.17% 70
2023
Q1
$2.42M Buy
10,001
+626
+7% +$154K 1.48% 28
2022
Q4
$2.46M Sell
9,375
-266
-3% -$71.3K 1.7% 23
2022
Q3
$2.17M Buy
9,641
+98
+1% +$23.8K 1.56% 27
2022
Q2
$2.32M Sell
9,543
-515
-5% -$126K 1.59% 25
2022
Q1
$2.43M Buy
10,058
+1,346
+15% +$309K 1.5% 27
2021
Q4
$1.96M Buy
+8,712
New +$1.84M 1.23% 32

Other funds holding AMGN

Leeward Financial Partners's AMGN Position: Q1 2025 in Review

Leeward Financial Partners sold out of Amgen (AMGN) in Q1 2025, closing a stake of 852 shares — an estimated $222K sold.

Leeward Financial Partners first reported a position in AMGN in Q4 2021 and held it in 8 quarters. The position peaked at $2.46M in Q4 2022. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Leeward Financial Partners reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Leeward Financial Partners sold 852 Amgen shares in Q1 2025, an estimated $222K.
  • Leeward Financial Partners first reported a position in Amgen in Q4 2021 and held it in 8 quarters.
  • Leeward Financial Partners's Amgen position peaked at $2.46M in Q4 2022.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Leeward Financial Partners's 13F filing for Q1 2025, filed 9 May 2025.